Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
News out this morning that BIXT is starting the dosing Optimization phase for the Phase III trial.
Longer it sits here the more I can load up. Tire kickers and waiters can pay more and chase when antivirals are approved for up 60+ viruses.
Hope they do before 2035. I mean this one has been trickling down for weeks. And pretty much since they got 500k from the university hedge fund
If it drops further I might add more but wow this hasn’t been a good investment even for insiders!
So far............but things will change.............
Z
Not enough people realize what $BIXT has........
Z
Just do a search for DDAmanda....will be the #1 Result.....all the info is on the site........
or Call/Text: 760 702-2009
Z
Apparently the market reaction is a big yawn.
Did he pay for them or did company award them ?
Working on any thing besides COVID ?
The historical pps chart says NO.
Does $BIXT have the cure for the Common Cold??
https://www.otcmarkets.com/stock/BIXT/news/Bioxytrans-Oral-Antiviral-Drug-to-Enter-Dose-Optimization-Clinical-Trial-for-COVID-19?id=431020
if you can or want to share where do I get this Amanda screener? and how do you use it
$BIXT: Is this news significant?
The cure for all viruses?...100% in Clinical Trials....... Wow.
https://www.otcmarkets.com/stock/BIXT/news/Bioxytrans-Oral-Antiviral-Drug-to-Enter-Dose-Optimization-Clinical-Trial-for-COVID-19?id=431020
With this discovery, we could use Nuclear Magnetic Resonance as a screening mechanism for viruses. In our COVID-19 case study we proved that the carbohydrate structures tested bound with high pico molar affinity, rarely seen with existing drugs, neutralize the viruses and that this data correlated with in vitro and the clinical trial results. We are at the dawn of a new age in virology that changes the current treatment paradigm of antivirals and vaccines to one of carbohydrate neutralization structures capable of efficiently neutralizing the virus to prevent cellular entry.”
About ProLectin-M
ProLectin-M is an oral galectin antagonist that prevents the entry of the SARS-CoV-2 virus into human cells. In recent clinical trials the drug achieved a 100% responders rate of negative PCR tests by day 7. In 3 days, the drug achieved an 88% responders rate of negative PCR tests. The treated population experienced no viral rebounds during the 14-day observation period. The company is preparing for a phase 3 clinical trial in order to seek regulatory approval.
Z
Looks like you were cheating on the CYDY people over here....so once again, as an "expert" on another drug, you decided to invest here???
I agree Mike.......past due for news.........
Z
Things are way too quiet lately at $BIXT which makes me think Major news is coming. CEO bought about $500,000 shares from the treasury and filed a form 4 just about the time things got real quiet, and the buy was like what he did months ago at about 3.5 times the current price last year.
I bought more BIXT this week. I smell major deal news brewing. It is too quiet, not to be major NDA deal stuff brewing. When a CEO dips into his own pocket and does that kind of dollars for share funding of the firm he runs, and he and the insiders own about 75% of the OS as restricted shares, wall-street better wake the F*ck up, but real investing and real DD has turned into slime-ville and mob-ville public muggings and programed money printing, by fake MM-HFT trading programs in public trading in the markets, unlike anything before. It is why China is kicking our asses in the science and manufacturing sectors for 30 years, with just a few exceptions.
But for me, it creates opportunities...
Form 4 was filed showing the CEO David Platt bought $500,000 of shares well above current prices, and he bought more than that months ago at about .345/share
MM's shorts are holding $BIXT down. I bought more this week.
I see a form 5 filed!
77,721 shares
> $11,000
$BIXT Video Analysis - from #DDAmanda
Many of mine have crossed the Rubicon the last 3 years, and BIXT will be one of the next ones this year. I hear they are recruiting folks for first of two parts of the Phase III in India already, the dosing trial, to set the dose for second part of the phase III.
Lots of other catalysts brewing already.
Holy Cow who said sugar molecules were baaaahhhdASS LOL
$BIXT Galectin Antagonists (antiviral molecules) Designed by AI, and could IMO end the need for many vaccines... Already has 2 Phase III trials in two countries ready:
Viruses trigger Neurological diseases published research is out:
BIXT can stop the virus:
Why BIXT?
https://www.cell.com/neuron/fulltext/S0896-6273(22)01147-3?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627322011473%3Fshowall%3Dtrue
https://www.dailystar.co.uk/news/latest-news/covid-morphed-stomach-bug-experts-31737142
BIXT has the potential to safe many lives and end much suffering!
Sounds exciting but maybe try some AI to help with these posts to fix the grammar mistakes !
Holy Cow who said sugar molecules were baaaahhhdASS LOL
$BIXT Galectin Antagonists (antiviral molecules) Designed by AI, and could IMO end the need for many vaccines... Already has 2 Phase III trials in two countries ready
https://cdn.discordapp.com/attachments/1151863925730709614/1189297970638770196/image.png?ex=659da70c&is=658b320c&hm=0d052d304423243a4482892e73081064016c79262a923a20137193cc387dbf3e&
Merry Christmas to all!
Note: many none performing stocks can many times fall victim to tax loss selling at the end of the year. Take advantage of this !
I’m adding all I can today, it’s like stealing candy from a baby!
Please read and share this with everyone, everyone you know!
https://www.zerohedge.com/news/2023-12-12/disease-x-resistance-futile
https://www.msn.com/en-us/health/medical/never-before-seen-virus-that-causes-malaria-like-illness-already-circulating/ar-AA1kYq4O?ocid=winp1taskbar&cvid=dc54595b97124bf69530bcf6fe4476f1&ei=46
Never-before-seen virus that causes malaria-like illness 'already circulating'
Story by Katherine Fidler •
14h
Need BIXT bad should be the main source of survival of this crap
Yes. The hardest thing in trading is to reenter a market at a higher price than where you exited it previously!
Ditto...All of my other stock choices have been egregious flops thus far and I'm hoping those two will redeem my portfolio some day...We'll see...
I'm certainly banking on it...And following the inevitable sell-off by profit-taking shareholders I'm keeping fingers and toes crossed that Bioxytran will turn into an industry Goliath like Nividia and Broadcom Semiconductors did after I bought and foolishly sold back when each stock was trading at $25... (Tickers NVDA & AVGO) Needless to say I get seriously ill when I take a look at where those two stocks are trading now versus where it was when I took my meager 20% profit on both years ago...Sigh...
When I click on that link I get an error message stating "PAGE NOT FOUND"...
Not everyone that owns a few shares posts daily..This is my first post..have owned Bixt shares for awhile and believe I am in the right place at the right time.$IFUS and $BIXT top two holdings
So true
Something is close to happening. I think in 60 days or less
.50 minimum coming soon for starters
BIG RIG
Or a JV or Multiple JV deals will send it flying. Once they get several versions to Market that patent could be worth 50 Billion dollars. They just need the non dilutive JV funding deal(s) to close and trials completed, and Boom, this turns into next Moderna stock rally like no one had seen before 2020..
Glad to see you here!
Enjoy thanksgiving!
I added $BIXT.
Interesting very recent article:
https://www.linkedin.com/pulse/galectin-antagonists-send-cancer-its-knees-who-strike-michael-sheikh-ykzmc%3FtrackingId=QJP3RG9YRNaoKUCfc6S8yA%253D%253D/?trackingId=QJP3RG9YRNaoKUCfc6S8yA%3D%3D
** ….. All of the article is very good… the last 2 paragraphs talk about Bixt…
Followers
|
46
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1236
|
Created
|
03/23/10
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |